|
J Biol Chem, Vol. 273, Issue 30, 19283-19293, July 24, 1998
Identification and Characterization of a Bovine Neurite Growth
Inhibitor (bNI-220)
Adrian A.
Spillmann ,
Christine E.
Bandtlow ,
Friedrich
Lottspeich¶,
Flavio
Keller , and
Martin E.
Schwab
From the Brain Research Institute, University of
Zürich and Swiss Federal Institute of Technology Zürich,
August Forelstrasse 1, 8029 Zürich, Switzerland and
¶ Genzentrum Martinsried, 82152 Martinsried, Germany
The poor axonal regeneration that follows lesions
of the central nervous system (CNS) is crucially influenced by the
local CNS tissue environment through which neurites have to grow. In addition to an inhibitory role of the glial scar, inhibitory substrate effects of CNS myelin and oligodendrocytes have been demonstrated. Several proteins including NI-35/250, myelin-associated glycoprotein, tenascin-R, and NG-2 have been described to have neurite outgrowth inhibitory or repulsive properties in vitro. Antibodies
raised against NI-35/250 (monoclonal antibody IN-1) were shown to
partially neutralize the growth inhibitory effect of CNS myelin and
oligodendrocytes, and to result in long distance fiber regeneration in
the lesioned adult mammalian CNS in vivo. We report here
the purification of a myelin protein to apparent homogeneity from
bovine spinal cord which exerts a potent neurite outgrowth inhibitory
effect on PC12 cells and chick dorsal root ganglion cells, induces
collapse of growth cones of chick dorsal root ganglion cells, and also
inhibits the spreading of 3T3 fibroblasts. These activities could be
neutralized by the monoclonal antibody IN-1. The purification procedure
includes detergent solubilization, anion exchange chromatography, gel
filtration, and elution from high resolution SDS-polyacrylamide gel
electrophoresis. The active protein has a molecular mass of 220 kDa and
an isoelectric point between 5.9 and 6.2. Its inhibitory activity is
sensitive to protease treatment and resists harsh treatments like 9 M urea or short heating. Glycosylation is, if present at
all, not detectable. Microsequencing resulted in six peptides and
strongly suggests that this proteins is novel.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. FitzGerald and J. Fawcett
Repair in the central nervous system
J Bone Joint Surg Br,
November 1, 2007;
89-B(11):
1413 - 1420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mingorance-Le Meur, B. Zheng, E. Soriano, and J. A. del Rio
Involvement of the Myelin-Associated Inhibitor Nogo-A in Early Cortical Development and Neuronal Maturation
Cereb Cortex,
October 1, 2007;
17(10):
2375 - 2386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P Liu, W. B.J Cafferty, S. O Budel, and S. M Strittmatter
Extracellular regulators of axonal growth in the adult central nervous system
Phil Trans R Soc B,
September 29, 2006;
361(1473):
1593 - 1610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C Maier and M. E Schwab
Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity
Phil Trans R Soc B,
September 29, 2006;
361(1473):
1611 - 1634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Dimou, L. Schnell, L. Montani, C. Duncan, M. Simonen, R. Schneider, T. Liebscher, M. Gullo, and M. E. Schwab
Nogo-A-Deficient Mice Reveal Strain-Dependent Differences in Axonal Regeneration
J. Neurosci.,
May 24, 2006;
26(21):
5591 - 5603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Fischer, V. Petkova, S. Thanos, and L. I. Benowitz
Switching Mature Retinal Ganglion Cells to a Robust Growth State In Vivo: Gene Expression and Synergy with RhoA Inactivation
J. Neurosci.,
October 6, 2004;
24(40):
8726 - 8740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Fischer, Z. He, and L. I. Benowitz
Counteracting the Nogo Receptor Enhances Optic Nerve Regeneration If Retinal Ganglion Cells Are in an Active Growth State
J. Neurosci.,
February 18, 2004;
24(7):
1646 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Oertle, M. E. van der Haar, C. E. Bandtlow, A. Robeva, P. Burfeind, A. Buss, A. B. Huber, M. Simonen, L. Schnell, C. Brosamle, et al.
Nogo-A Inhibits Neurite Outgrowth and Cell Spreading with Three Discrete Regions
J. Neurosci.,
July 2, 2003;
23(13):
5393 - 5406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fiedler, C. Horn, C. Bandtlow, M.E. Schwab, and A. Skerra
An engineered IN-1 Fab fragment with improved affinity for the Nogo-A axonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity
Protein Eng. Des. Sel.,
November 1, 2002;
15(11):
931 - 941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Bareyre, B. Haudenschild, and M. E. Schwab
Long-Lasting Sprouting and Gene Expression Changes Induced by the Monoclonal Antibody IN-1 in the Adult Spinal Cord
J. Neurosci.,
August 15, 2002;
22(16):
7097 - 7110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Kwon, J. F. Borisoff, and W. Tetzlaff
Molecular Targets for Therapeutic Intervention after Spinal Cord Injury
Mol. Interv.,
July 1, 2002;
2(4):
244 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Huber, O. Weinmann, C. Brosamle, T. Oertle, and M. E. Schwab
Patterns of Nogo mRNA and Protein Expression in the Developing and Adult Rat and After CNS Lesions
J. Neurosci.,
May 1, 2002;
22(9):
3553 - 3567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Grandpre and S. M. Strittmatter
Nogo: A Molecular Determinant of Axonal Growth and Regeneration
Neuroscientist,
October 1, 2001;
7(5):
377 - 386.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Brosamle, A. B. Huber, M. Fiedler, A. Skerra, and M. E. Schwab
Regeneration of Lesioned Corticospinal Tract Fibers in the Adult Rat Induced by a Recombinant, Humanized IN-1 Antibody Fragment
J. Neurosci.,
November 1, 2000;
20(21):
8061 - 8068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.I. Shifman and M.E. Selzer
Expression of the Netrin Receptor UNC-5 in Lamprey Brain: Modulation by Spinal Cord Transection
Neurorehabil Neural Repair,
January 1, 2000;
14(1):
49 - 58.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Niederost, D. R. Zimmermann, M. E. Schwab, and C. E. Bandtlow
Bovine CNS Myelin Contains Neurite Growth-Inhibitory Activity Associated with Chondroitin Sulfate Proteoglycans
J. Neurosci.,
October 15, 1999;
19(20):
8979 - 8989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T.J. Belien, P. A. Paganetti, and M. E. Schwab
Membrane-type 1 Matrix Metalloprotease (MT1-MMP) Enables Invasive Migration of Glioma Cells in Central Nervous System White Matter
J. Cell Biol.,
January 25, 1999;
144(2):
373 - 384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Fields, M. E. Schwab, and J. Silver
Does CNS Myelin Inhibit Axon Regeneration?
Neuroscientist,
January 1, 1999;
5(1):
12 - 18.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Matern, H. Boermans, F. Lottspeich, and S. Matern
Molecular Cloning and Expression of Human Bile Acid beta -Glucosidase
J. Biol. Chem.,
October 5, 2001;
276(41):
37929 - 37933.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|